References
- Gandhi R, Lal Kaul C, Panchagnula R. Extrusion and spheronization in the development of oral controlled-release dosage forms. Pharm Sci Technol Today 1999;2:160–170.
- Ueda H, Ou D, Endo T, Nagase H, Tomono K, Nagai T. Evaluation of a sulfobutyl ether-cyclodextrin as a solubilizing/stabilizing agent for several drugs. Drug Dev Ind Pharm 1998;24:863–867.
- Fernández M, Rodrígues IC, Margarit M., Cerezo A. Characterization of solid dispersions of piroxicam/polyethylene glycol 4000. Int J Pharm 1992;84:197–202.
- Habib MJ, Phan MT, Owusu-Ababio G. Dissolution profiles of flurbiprofen in phospholipid solid dispersions. Drug Dev Ind Pharm 1998;24:1077–1082.
- Kazarian SG, Martirosyan GG. Spectroscopy of polymer/drug formulations processed with supercritical fluids: In situ ATR-IR and Raman study of impregnation of ibuprofen into PVP. Int J Pharm 2002;232:81–90.
- Leuner Ch, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60.
- Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm 1996;143:59–66.
- Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone, Int J Pharm 1999;181:143–151.
- Sheth A, Bates S, Muller F, Grant D. Polymorphism in piroxicam. Crystal Growth Design 2004;4:1091–1098.
- Vrečer F, Vrbinc M, Meden A. Characterization of piroxicam crystal modifications. Int J Pharm 2003;256:3–15.
- Reynolds JEF. Martindale. The extra pharmacopoeia. 29th ed. London: The Pharmaceutical Press; 1989.
- Yu L. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Rev 2001;48:27–42.
- Ghan GA, Lalla JK. Effect of compressional forces on piroxicam polymorphs. J Pharm Pharmacol 1992;44:678–681.